MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ana.25905

Медицинская библиотека · Annals of neurology · 2020

Alzheimer-Related Cerebrovascular Disease in Down Syndrome.

Lao Patrick J, Gutierrez José, Keator David, Rizvi Batool, Banerjee Arit, Igwe Kay C, Laing Krystal K, Sathishkumar Mithra, Moni Fahmida, Andrews Howard, Krinsky-McHale Sharon, Head Elizabeth, Lee Joseph H, Lai Florence, Yassa Michael A, Rosas H Diana, Silverman Wayne, Lott Ira T, Schupf Nicole, Brickman Adam M

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

OBJECTIVE

Adults with Down syndrome (DS) develop Alzheimer disease (AD) pathology by their 5th decade. Compared with the general population, traditional vascular risks in adults with DS are rare, allowing examination of cerebrovascular disease in this population and insight into its role in AD without the confound of vascular risk factors. We examined in vivo magnetic resonance imaging (MRI)-based biomarkers of cerebrovascular pathology in adults with DS, and determined their cross-sectional relationship with age, beta-amyloid pathology, and mild cognitive impairment or clinical AD diagnostic status.

METHODS

Participants from the Biomarkers of Alzheimer's Disease in Down Syndrome study (n = 138, 50 ± 7 years, 39% women) with MRI data and a subset (n = 90) with amyloid positron emission tomography (PET) were included. We derived MRI-based biomarkers of cerebrovascular pathology, including white matter hyperintensities (WMH), infarcts, cerebral microbleeds, and enlarged perivascular spaces (PVS), as well as PET-based biomarkers of amyloid burden. Participants were characterized as cognitively stable (CS), mild cognitive impairment-DS (MCI-DS), possible AD dementia, or definite AD dementia based on in-depth assessments of cognition, function, and health status.

RESULTS

There were detectable WMH, enlarged PVS, infarcts, and microbleeds as early as the 5th decade of life. There was a monotonic increase in WMH volume, enlarged PVS, and presence of infarcts across diagnostic groups (CS < MCI-DS < possible AD dementia < definite AD dementia). Higher amyloid burden was associated with a higher likelihood of an infarct.

INTERPRETATION: The findings highlight the prevalence of cerebrovascular disease in adults with DS and add to a growing body of evidence that implicates cerebrovascular disease as a core feature of AD and not simply a comorbidity. ANN NEUROL 2020;88:1165-1177.

Для цитирования: Lao Patrick J, Gutierrez José, Keator David, Rizvi Batool, Banerjee Arit, Igwe Kay C, Laing Krystal K, Sathishkumar Mithra, Moni Fahmida, Andrews Howard, Krinsky-McHale Sharon, Head Elizabeth, Lee Joseph H, Lai Florence, Yassa Michael A, Rosas H Diana, Silverman Wayne, Lott Ira T, Schupf Nicole, Brickman Adam M. Alzheimer-Related Cerebrovascular Disease in Down Syndrome.. Annals of neurology. 2020. DOI: 10.1002/ana.25905.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.